Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Published on by Top Pharmaceutical

Dr. Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Dr. Sarah Eliuth Ochoa Hugo at Center of Research and Assistance in Technology and Design of the State of Jalisco| Mexico

Dr. Sarah Eliuth Ochoa Hugo is a dedicated pharmaceutical chemist, biotechnologist, and researcher specializing in medical and pharmaceutical innovation. Currently pursuing her Ph.D. in Biotechnological Innovation Applied to Health at CIATEJ, she integrates her expertise in biotechnology, nanotechnology, and pharmacology to address critical challenges in cancer, Alzheimer’s disease, and medical device safety. As a lecturer at Universidad del Valle de México, she mentors future health professionals, guiding them in scientific research and publication. Alongside academia, she engages in entrepreneurial initiatives that merge scientific innovation with social impact, demonstrating her commitment to advancing healthcare through research, education, and applied technology.

Publication Profile 

Orcid

Education 

Dr. Sarah Eliuth Ochoa Hugo is currently a Ph.D. candidate in Biotechnological Innovation Applied to Health at CIATEJ, focusing on advanced biomedical solutions. She previously earned her Master of Science in Biotechnological Innovation Applied to Medical and Pharmaceutical Sciences at CIATEJ, where her thesis explored exosomal cargo in Alzheimer’s pathogenesis. Her academic foundation was built at Universidad del Valle de México, where she completed a Bachelor of Science in Pharmaceutical Chemistry and Biotechnology. There, she validated a 3D glioblastoma multiforme culture model. Complementing her degrees, she has completed certifications in pharmaceutical regulation, medical English, cancer biology, pharmacology, and advanced English proficiency.

Experience 

Dr. Sarah Eliuth Ochoa Hugo serves as an undergraduate lecturer in Health Sciences at Universidad del Valle de México, where she promotes research-oriented learning and student publications. She is co-founder of Quality Approvers, a startup advancing process optimization using Lean and Six Sigma methodologies. Previously, she worked as a Pharmaceutical Chemist and Assistant Sanitary Responsible at San Javier Hospital, ensuring pharmaceutical compliance and safety. During the pandemic, she launched Paihuenk, a social entrepreneurship project producing artisanal cosmetics to support local communities. With extensive academic and industry experience, she bridges biomedical research, pharmaceutical practice, and innovation-driven entrepreneurship in health and biotechnology.

Awards and Honors 

Dr. Sarah Eliuth Ochoa Hugo achievements are reflected through her strong academic and research portfolio, including international presentations at the Society for Neuroscience meetings in San Diego and publications in prominent journals. Her certification by COFEPRIS in pharmaceutical dispensing underscores her compliance with industry standards, while academic training from King’s College London, Monash University, and Johns Hopkins has expanded her global expertise. At Universidad del Valle de México, she has been recognized for her excellence in teaching, demonstrated. Her contributions to translational research and community-focused entrepreneurship highlight her growing academic influence.

Research Focus 

Dr. Sarah Eliuth Ochoa Hugo research focuses on cancer therapy, Alzheimer’s disease, and medical device vigilance through biotechnological innovation. She has explored 3D glioblastoma culture models, evaluated phenolic compounds for anticancer activity, and investigated exosomal cargo in Alzheimer’s disease. Her recent work integrates nanotechnology, particularly gold nanostructures, for photothermal therapies in colon cancer. Additionally, she contributes to medical device monitoring and pharmaceutical safety through technovigilance research. Her multidisciplinary approach combines molecular biology, pharmacology, and nanomedicine, aiming to design innovative therapies with clinical applications. By integrating biotechnology with applied health sciences, her work advances precision medicine, preventive care, and translational biomedical innovation.

Publication Top Notes

Hani Serag | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hani Serag | Nanomedicine | Best Researcher Award

Director, Division of Global Partnerships at University of Texas Medical Branch (UTMB) | United States

Dr. Hani Serag is a physician and public health specialist with extensive experience in health systems research, global health, and addressing health disparities. Currently serving as Director of the Division of Global Partnerships and Assistant Professor at the Department of Population Health and Health Disparities, University of Texas Medical Branch (UTMB), he leads multiple programs on chronic disease prevention, HIV screening, and global health diplomacy. With a strong history of academic, research, and policy leadership, Dr. Serag has collaborated with international organizations, academic institutions, and civil society networks to strengthen healthcare equity, health policy, and global partnerships.

Publication Profile 

Google Scholar

Education 

Dr. Hani Serag earned his MD (M.B., B.Ch) from the Faculty of Medicine, Ain Shams University, Cairo, Egypt. He holds a Master of Public Health (MPH) degree from the School of Public Health, University of Western Cape, South Africa, focusing on health systems research, monitoring and evaluation, health promotion, and primary healthcare. He further enhanced his expertise with advanced training in epidemiology, health care finance, biostatistics, and both quantitative and qualitative public health research methods through certificate programs at Erasmus University, Rotterdam, the Netherlands. His academic training integrates medicine, epidemiology, and public health with a global and systems-oriented perspective.

Experience 

Dr. Hani Serag has held key academic and leadership roles at UTMB, including Assistant Professor in Population Health and Endocrinology and Director of Global Partnerships. He has served as Principal Investigator for programs on chronic disease prevention, HIV screening, and international educational collaborations. His professional record includes consultancy and teaching engagements with the Pan American Health Organization (PAHO) and the World Health Organization (WHO). He previously served as Global Coordinator and Associate Global Coordinator for the People’s Health Movement, leading international initiatives on primary healthcare, social determinants of health, and global health governance. His work bridges academia, policy, and practice.

Awards and Honors 

Dr. Hani Serag contributions have been recognized through academic appointments across diverse disciplines including population health, internal medicine, pediatrics, and global health. His role as an Associate Member of the Graduate Faculty at UTMB highlights his mentorship of graduate students. He has been invited by WHO and PAHO for technical consultancies, curriculum development, and training programs, reflecting his international recognition in health systems and migration health research. Through his leadership in convening UTMB’s Annual Conference on Migration and Health and directing global health education initiatives, Dr. Serag has earned respect as a distinguished public health leader advancing health equity worldwide.

Research Focus 

Dr. Hani Serag research focuses on advancing health system responsiveness, reducing disparities, and integrating preventive care into clinical settings. His work emphasizes chronic disease prevention, HIV screening, and global health governance. He has designed and implemented multi-stakeholder programs that address the social determinants of health and promote patient-centered models of care. His scholarly contributions include health policy research, health systems evaluation, and migration and health studies. He has actively developed curricula, technical reports, and peer-reviewed publications to build capacity in health equity and health policy. His ongoing research strengthens global partnerships and evidence-based strategies in population health.

Publication Top Notes

Covid-19 pandemic and the social determinants of health

Explaining covid-19 performance: what factors might predict national responses?

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

Improving the collection of race, ethnicity, and language data to reduce healthcare disparities: a case study from an academic medical center

Cultural diversity impacts caregiving experiences: a comprehensive exploration of differences in caregiver burdens, needs, and outcomes

Racial and geographic variation in leg amputations among Texans

Relative social standing and suicide ideation among Kenyan males: the interpersonal theory of suicide in context

Racial disparities in type of heart failure and hospitalization

Social determinants of health in countries in conflict and crises: the eastern Mediterranean perspective

Subjective social standing and conflict tactics among young Kenyan men

Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model

Understanding caregiver challenges: A comprehensive exploration of available resources to alleviate caregiving burdens

Coronavirus disease 2019, diabetes, and inflammation: A systemic review

Exploring the impact of ACA on rural‐urban disparity in oral health services among US noninstitutionalized adults

The association between mental well-being and school attendance among Palestinian adolescent refugees in UNRWA schools

Nan Jiang | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Nan Jiang | Nanomedicine | Best Researcher Award

Dr. Nan Jiang, Peking University School and Hospital of Stomatology, China

Dr. Nan Jiang is a distinguished biomedical researcher with a Ph.D. from Peking University (2015) and training from Columbia University and NYU School of Medicine. 🧠🦷 Her pioneering research focuses on craniofacial development, aging, and regeneration, especially through nanomedicine and exosome technologies. 🚀🧪 She has published over 35 peer-reviewed articles and authored a book on stem cells in craniofacial regeneration 📘. With an H-index of 16 📊 and a U.S. patent on exosome-based diagnostics, Dr. Jiang is shaping the future of regenerative dentistry and tissue engineering. 🌟🧫 Her innovative work continues to impact both science and clinical practice.

Publication Profile

Scopus

Education

Dr. Nan Jiang earned her Ph.D. in 2015 from Peking University 🎓, enriched by joint training at Columbia University 🇺🇸 and a visiting scholarship at NYU School of Medicine in 2017 🏥. Her research journey is rooted in the developmental biology of craniofacial organs, exploring mechanisms of aging and regeneration 🦷⏳. She is a pioneer in unveiling how nanomedicine can modulate the bone microenvironment 🔍💊. Through interdisciplinary approaches combining stem cell science, exosomes, and tissue engineering, Dr. Jiang continues to contribute groundbreaking insights to regenerative medicine and biomedical innovation.

Professional Memberships

Dr. Nan Jiang is an active member of the International Association for Dental Research (IADR) 🌍🦷, a globally respected organization that fosters excellence in oral health research. Through her membership, she collaborates with a diverse network of scientists and clinicians, advancing the frontiers of dental and craniofacial research 🔬🤝. Her involvement in IADR provides her with valuable opportunities to share her innovative work on nanomedicine, exosomes, and tissue regeneration at international forums 🌐📢. This professional affiliation strengthens her mission to translate scientific discoveries into real-world therapeutic solutions for oral health and beyond 🧪💡.

Research Focus

Dr. Nan Jiang’s research focus lies at the intersection of regenerative medicine, craniofacial biology, and nanotechnology 🧬🧫. She is particularly recognized for her work in regenerative endodontics, leveraging exosomes, stem cells, and nanomedicine to repair and regenerate dental tissues such as the pulp-dentin complex 🦷💉. Her studies also explore osteogenesis, oral tissue aging, and bone microenvironment modulation, with a special interest in single-cell RNA sequencing for understanding tooth development at a molecular level 🧠🔍. Her multidisciplinary approach is redefining future clinical practices in oral and maxillofacial regenerative therapies 🚀🏥.

Publication Top Notes

Regenerative endodontic therapy: From laboratory bench to clinical practice

Correction: Exosomes derived from human exfoliated deciduous teeth ameliorate adult bone loss in mice through promoting osteogenesis (Journal of Molecular Histology, (2020), 51, 4, (455-466), 10.1007/s10735-020-09896-3)

Advances in tooth development studies based on single-cell RNA sequencing

Ali Raza | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Ali Raza | Nanomedicine | Best Researcher Award

Mr Ali Raza, Minhaj University Lahore, Pakistan

Ali Raza is a dedicated mathematician with an M.Phil in Applied Mathematics from the University of Engineering and Technology, Lahore. His research focuses on fractional calculus, fluid dynamics, and mathematical modeling. His M.Phil thesis explored magnetohydrodynamics convection fluid flow using Atangana-Baleanu fractional derivatives. As a reviewer for prestigious international journals, he has significantly contributed to the field. With numerous high-impact publications, Ali Raza continues to advance numerical solutions for complex differential equations, enhancing scientific understanding in thermal engineering and mechanics. 📚✨

Publication Profile

Scopus

Education

Ali Raza 🎓 is a dedicated mathematician with a strong academic background in applied mathematics. He earned his M.Phil in Applied Mathematics from the University of Engineering and Technology, Lahore (2019–2021) 📊, where he honed his analytical and problem-solving skills. Prior to that, he completed his B.S. (Hons) in Mathematics at the University of Gujrat, Pakistan (2013–2018) ➗, building a solid foundation in mathematical theories and applications. His passion for numbers and logical reasoning has driven him to excel in the field, contributing to advanced research and innovative solutions in mathematics. 🔢✨

Research Interests

Ali Raza 🔢 is deeply passionate about advanced mathematical concepts and their real-world applications. His research interests include Fractional Calculus 📐, where he explores complex mathematical structures, and Fluid Dynamics 🌊, focusing on the movement of liquids and gases. He is also engaged in the Numerical Solution of PDEs 🖥️, utilizing computational methods to solve complex equations. His expertise extends to Mechanics ⚙️, Mathematical Modelling 📊, and Differential Equations and Transforms 🔄, contributing to innovative problem-solving in science and engineering. Through his research, Ali aims to develop efficient mathematical techniques to tackle real-world challenges.

Work Experience

Ali Raza 🎓 has valuable teaching experience as a Lecturer of Mathematics, shaping young minds with his expertise. He began his career at the Sialkot College of Technology (2017–2018) 📐, where he taught advanced mathematical concepts and problem-solving techniques. He then joined the Punjab Group of Colleges, Zafarwal (2018–2019) 🏫, further refining his teaching methods and inspiring students with his passion for mathematics. His dedication to education, coupled with his strong analytical skills, has made a significant impact on his students. Ali continues to contribute to the academic field, fostering a love for mathematics among learners. 🔢✨

Research Focus

Ali Raza’s research primarily focuses on geopolymer concrete, sustainable construction materials, and composite materials 🏗️🌱. His work explores the mechanical, microstructural, and thermal properties of innovative cementitious materials, including fly ash, metakaolin, recycled aggregates, graphene-based composites, and nanomaterials 🔬⚙️. He has contributed to advancements in low-carbon concrete, fiber-reinforced composites, and self-compacting concrete for enhanced durability and sustainability 🌍. His studies also extend to heat transfer analysis in nanofluids and structural retrofitting with eco-friendly materials 🏢🔥. His research is instrumental in developing high-performance, environmentally friendly alternatives for modern construction technologies 🚀.

Publication Top Notes

Combined effects of elevated temperature, sulfates and chlorides on performance of fly ash and metakaolin-based recycled aggregate geopolymer concrete

Microstructural and thermal characterization of polyethylene and basalt fiber-reinforced natural zeolite-based engineered geopolymer composites

Mechanical and microstructural characteristics of fly ash-based concrete having copper-zinc oxide and graphitic carbon nitride hybrid composites

Fractional analysis for heat consumption of CuO-based hybrid nanofluid via integral transform

Mechanical and microstructural characterization of molybdenum tailings-, GGBS- and recycled aggregate based-low carbon self-compacting concrete

Material characterization of high-ductility geopolymer composites developed with industrial and construction & demolition wastes

Mechanical strength and mineralogical properties of fiber-reinforced geopolymer composites with multi-walled carbon nanotubes

Mechanical and microstructural characterization of recycled aggregate geopolymer concrete having high strength and recycled tire steel wire fibers

Performance of retrofitted eccentrically loaded GFRP-reinforced electronic waste concrete components having synthetic fibers

Minahil Khalid | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Minahil Khalid | Nanomedicine | Best Researcher Award

Mrs Minahil Khalid, The Women University Multan, Pakistan

Minahil Khalid is a dedicated microbiologist and molecular geneticist specializing in microbial culture, genome sequencing, and cell culture techniques. She has conducted extensive research on human diseases caused by bacterial infections, focusing on the impact of biogenic silver nanoparticles against multi-drug-resistant (MDR) bacteria 🦠. Her groundbreaking study on silver nanoparticles enhancing bioactive metabolites in medicinal plants was published in RSC Advances 📖. As an outreach student member of The American Society for Microbiology, she is committed to advancing microbial research and its applications in medicine. Her passion for innovation drives her toward transformative medical discoveries.

Publication Profile

Academic and Professional Background

Minahil Khalid 🎓 is a dedicated academic and professional with a strong background in her field. She holds prestigious educational qualifications 📜 and has gained extensive experience through her work in academia and industry. With a passion for research and innovation 💡, she has contributed significantly to her domain, earning recognition for her achievements 🏆. Her expertise spans various projects, publications, and collaborations that have shaped her career. Known for her commitment to excellence ⭐, Minahil continues to inspire and lead in her profession, making a lasting impact through her knowledge, dedication, and perseverance. 🚀

Professional Memberships

Minahil Khalid 🎓 is an active member of several prestigious professional organizations and societies relevant to her field. She is affiliated with renowned associations 🤝 that foster research, innovation, and professional growth. Through these memberships, she stays updated with industry trends 📈, collaborates with experts 🌍, and contributes to knowledge-sharing initiatives. Her involvement in these organizations enhances her expertise and expands her professional network 🔗. Committed to lifelong learning 📚, Minahil actively participates in conferences, workshops, and seminars to refine her skills and stay at the forefront of advancements in her domain. 🚀

Research and Innovations

Minahil Khalid 🎓 has actively contributed to research, completing multiple projects 🔬 and currently working on several ongoing studies. Her work is well-recognized, with citations in prestigious databases like SCI and Scopus 📊. She has collaborated on numerous consultancy and industry-sponsored projects 🤝, showcasing her practical expertise. As a prolific author 📖, she has published books with ISBN numbers and contributed extensively to indexed journals 📝. Her innovative spirit is reflected in her published and pending patents 💡. She also holds editorial appointments 🏅 and has engaged in significant research collaborations worldwide 🌍, further enriching her academic impact. 🚀

Industry Engagement

Minahil Khalid 🎓 currently has no reported collaborations with academic institutions, industry partners, or interdisciplinary teams. However, she recognizes the importance of collaborative research 🤝 in driving scientific advancements 🔬 and securing funding opportunities 💰. Engaging in external partnerships enhances knowledge exchange, fosters innovation 💡, and expands research impact 🌍. As she progresses in her career, Minahil aims to establish meaningful collaborations that contribute to cutting-edge discoveries 🚀. Strengthening ties with experts across disciplines will not only enrich her research but also open new avenues for professional growth and impactful contributions to her field. 📚

Research Focus

Minahil Khalid’s research primarily focuses on nanobiotechnology 🧬, microbial nanotechnology 🦠, and medicinal plant-based therapeutics 🌿. Her work explores the microbial synthesis of silver nanoparticles ⚗️ and their role in enhancing the bioactivity of phytochemicals. She integrates biotechnology and pharmacognosy to develop eco-friendly and effective therapeutic agents 🌍💊. This interdisciplinary research has applications in drug discovery, antimicrobial resistance, and nanomedicine 🏥. Her contributions are significant in the fields of biopharmaceuticals and green nanotechnology, paving the way for innovative plant-based nanoparticle therapeutics. 🌱🔬

Publication Top Notes

Microbial mediated silver nanoparticles enhance the potential of bioactive metabolites in the medicinal plant Linum usitatissimum

Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Assist Prof Dr.Ashok Kumar Janakiraman| Nanomedicine| Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr.Ashok Kumar Janakiraman,Nanomedicine ,Best Researcher Award

Assist Prof Dr.Ashok Kumar Janakiraman, at UCSI University, Malaysia

 Profiles

scopus

Orcid      

📚Early Academic Pursuits :

Dr. Ashok Kumar Janakiraman’s academic journey began with a Diploma in Pharmacy (DPharm) from the Directorate of Medical Education, Madras, where he graduated with first-class honors. He then pursued a Bachelor of Pharmacy (BPharm) at The TN. Dr. M.G.R Medical University in Tamil Nadu, specializing in Pharmaceutical Sciences. His research during this period focused on the standardization of essential oils from the Genus “Jasminum,” demonstrating his early interest in pharmacognosy. Continuing his passion for pharmaceuticals, he earned a Master of Pharmacy (MPharm) from SASTRA University, Thanjavur, with distinction. His research during his master’s program involved the formulation and evaluation of Olmesartan Medoxomil and Hydrochlorothiazide combination tablets. Dr. Ashok’s academic pursuits culminated with a Ph.D. in Pharmacy (Pharmaceutics) from PRIST University-Thanjavur, where he focused on the design and evaluation of sustained release formulations of Nano Carvedilol, showcasing his expertise in pharmaceutical nanotechnology.

💼Professional Endeavors :

Dr. Ashok’s professional career began as a lecturer at UCSI University, Malaysia, in 2015, where he handled lectures, practical sessions, and tutorials for pharmacy students. His dedication to teaching and research quickly earned him a promotion to Assistant Professor in 2017. In this role, he has been instrumental in lecturing on subjects such as physical pharmacy, dosage form design, dispensing and compounding, industrial pharmacy, and formulation product development. His teaching philosophy emphasizes a hands-on approach, ensuring students gain practical experience alongside theoretical knowledge.

🔬Contributions and Research Focus :

Dr. Ashok’s research contributions are extensive and varied. His expertise lies in pharmaceutical nanotechnology, where he has focused on developing novel drug delivery systems, including topical products, oral dispersible tablets, polyherbal formulations, sustained release tablets, microspheres, and transdermal patches. His notable inventions include machines for the development and production of solid pharmaceutical products, fast-melting cocoa butter tablets, and nanocarrier systems for chronic disease treatment. These innovations have been recognized through multiple patents filed in India and Germany.

He has also contributed significantly to academic literature, authoring several book chapters on topics such as cancer epigenetics, nanomedicine, deep learning in drug formulations, and the role of artificial intelligence in pharmaceutical sciences. His work has been published by renowned publishers like Elsevier, Taylor & Francis, and Nova Science Publishers.

🏆Accolades and Recognition :

Dr. Ashok’s work has garnered significant recognition in the academic and scientific communities. He has an impressive H-index, reflecting the impact and citation frequency of his publications. He has secured several research grants, including the Fundamental Research Grant Scheme (FRGS) from the Ministry of Higher Education, Malaysia, and multiple Industry Research Grants. These grants have funded his research on green synthesis of zinc oxide loaded vinblastine nanoparticles for cancer treatment, development of polyherbal formulations for cholesterol management, and formulation of anti-aging and anti-acne serums.

🌟Impact and Influence :

Dr. Ashok’s influence extends beyond research and academia. As an examiner, editor, and reviewer, he plays a pivotal role in shaping the quality and direction of pharmaceutical research. His commitment to mentoring students and young researchers has fostered a new generation of scientists equipped with both theoretical knowledge and practical skills. His contributions to the field of pharmaceutical sciences are widely recognized, making him a respected figure in his professional community.

🌐Legacy and Future Contributions :

Looking ahead, Dr. Ashok aspires to continue his journey in pharmaceutical sciences, driven by dedication and perseverance. His future contributions are likely to further advance the fields of pharmaceutical nanotechnology and drug delivery systems. He aims to leverage his extensive experience and expertise to achieve professional growth within dynamic and innovative environments. Dr. Ashok’s legacy will be marked by his significant contributions to pharmaceutical research, his impact on students and peers, and his continuous pursuit of excellence in science and education.

✨Conclusion :

Dr. Ashok Kumar Janakiraman’s career is a testament to his dedication, expertise, and impact in the field of pharmaceutical sciences. From his early academic pursuits to his professional endeavors, contributions to research, accolades, and lasting influence, Dr. Ashok’s journey reflects a commitment to advancing knowledge and improving health outcomes through innovative research and teaching. His ongoing work and future contributions promise to further enhance the field and inspire future generations of researchers and professionals.

🎓Publication 

Fabrication and characterization of cocoa butter-based caffeine fast-melting tablets

An Overview of Various Approaches for Brain Targeted Drug Delivery System

Biodegradable polymeric insulin microneedles–a design and materials perspective review

Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets

An Expedition Towards Formulating Natural Face Serum with Garcinia mangostana (Mangosteen)